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Abstract
Sudden arrhythmic death syndrome (SADS) is due to genetic conditions associated with
cardiac ion channelopathies and cardiomyopathies. Many of these conditions have
exercise guidelines regarding eligibility and disqualification recommendations for
competitive athletes through the American Heart Association and the American College
for Cardiology. This study investigates how medical professionals communicate these
exercise recommendations to patients, and in turn, how well patients understand these
recommendations. The study also explores motivations for either continuing or
discontinuing an exercise practice after a diagnosis. A questionnaire was distributed
through cardiac disease-focused support groups and organizations. Data from 67
individuals with a SADS condition were analyzed for possible associations and
significant differences. Results demonstrated that intensity of exercise on a 1 to 9 scale
decreased from 4.9 to 3.3 after a diagnosis (p < .01). Time spent exercising decreased
from 204 minutes per week to 142 min/week after a diagnosis (p < .01). Patients were
significantly more likely to decrease activity intensity when they felt confident with the
communication of their exercise recommendations and how well they understood them.
This study showed that individuals felt poorly informed regarding their exercise
recommendations and often take on heavy emotional burdens due to restrictive
guidelines. The respondents widely expressed that quality of life is an important factor in
their decisions about exercise, and that continuing exercise is a major component of a
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healthy lifestyle despite risks associated with SADS. Involving genetic counselors in the
discussion of exercise guidelines is recommended while addressing the psychosocial
outcomes of a recent diagnosis. This addition to the management of individuals with a
SADS diagnosis is likely to increase awareness of how exercise recommendations are
managed and how well patients understand that their personalized exercise plan will
promote a safer healthcare management plan for each patient.
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Chapter 1: Background
1.1 Overview of Electrophysiologic and Structural Congenital Heart Disease
Congenital heart disease (CHD) is the most common birth defect and is defined as
a number of different problems affecting the heart at the time of birth. Although
congenital, some of these problems may not show physical presentations until years later.
Sudden Cardiac Death (SCD), causing an estimated 325,000 adult deaths in the United
States each year, is defined as an unexplained death caused by loss of heart function
(Napolitano, Bloise, Monteforte, & Priori, 2012). Some genetic cardiovascular diseases
can result in SCD and include but are not limited to cardiomyopathies and
channelopathies. Specifically, each diagnosis has its own etiology, incidence, genetic
cause, and risk of SCD (Sheikh et al., 2015). Research on these congenital heart diseases
has primarily focused on young athletes to better determine the epidemiology of each
individual classification of disease.
Cardiomyopathies refer to diseases of the heart muscle, where the muscle tissue
becomes enlarged, thick, or rigid. In rare and severe cases, the muscle tissue is replaced,
making the heart weaker and prone to arrhythmias. Hypertrophic cardiomyopathy (HCM)
is typically an inherited genetic condition that leads to a thickened heart muscle around
the left ventricle, making it rigid and dysfunctional. Specifically, thickening occurs in the
interventricular septum, which separates the right and left ventricle. In severe cases, the
septum can obstruct the flow of oxygen-rich blood from exiting the heart. This can lead
to symptoms including fatigue, syncope, and feeling out of breath. Sometimes the
1

thickening and scarring of the heart muscle changes the integrity of the communication
between cells, causing arrhythmias (National Library of Medicine, 2016). These
arrhythmias and possible SCD are often more likely to occur during intense physical
activity (Sheikh et al., 2015).
The prevalence of HCM is assumed to be 1 in 500, and is known to be the leading
identified cause of SCD in competitive athletes (Maron, Haas, Ahluwalia, Murphy, &
Garberich, 2016b). As the most common genetic heart disease in the United States,
cardiovascular physicians and genetic counselors recognize the variable expressivity of
the condition. Age of onset can range from childhood to late adulthood, with some
individuals never showing signs or symptoms at all. Dozens of genes can cause
hypertrophic cardiomyopathy, with the most common being MYH7, MYBPC3, TTNT2,
and TNNI3. All of these genes play important roles in forming sarcomeres, which are the
basic units of muscle contraction. Hypertrophic cardiomyopathy is a perfect example of
genetic heterogeneity, and each individual case is unique (Maron et al., 2015).
Another common genetic cardiomyopathy that can cause SCD is arrhythmogenic
right ventricular cardiomyopathy (ARVC). In ARVC, the proteins holding the heart
muscle cells together do not develop properly, leading to fatty deposits that build up in an
attempt to repair the damage. This usually affects the right side of the heart and can cause
arrhythmias, which can lead to SCD, especially during strenuous exercise (Napolitano
et al., 2012).
The frequency of ARVC is estimated to be 1 in 1,000 to 1 in 1,250, but may be
under-diagnosed due to the difficulty in diagnosing the condition. Unfortunately, most
affected individuals do not show signs or symptoms until a severe cardiac event happens,
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which is typically in adulthood. The most common genetic changes are in the PKP2
gene, which is involved in the function of desmosomes. Desmosomes act as the cell-tocell “superglue” that play a role in signaling between neighboring cells and give strength
to the heart muscle itself (National Library of Medicine, 2016).
Channelopathies are diseases that result from the dysfunction of ion channels
located in the membranes of cells, and specifically in cardiac tissue. These diseases can
lead to irregular heart rhythms, syncope, arrhythmias, and SCD. A common example of a
channelopathy is long QT syndrome (LQTS). LQTS is an arrhythmogenic disorder that
presents with a prolongated QT interval (> 440 milliseconds in males and > 460 ms in
females). LQTS exists with a variety of genotypes, meaning that the condition may be
caused by a deleterious mutation in one of several genes. Each unique genotype is
typically associated with a different complex phenotype, differing arrhythmogenic
triggers, and mutations in various genes (Basavarajaiah et al., 2007). LQTS1 is associated
with cardiac events during exercise, LQTS2 events are triggered by alarm clocks or
moments of surprise, and events in LQTS3 typically occur during sleep. These events can
occur from infancy to adulthood (National Library of Medicine, 2016).
The prevalence of all LQTS types is estimated to be 1 in 2,000. Genetic changes
in genes that provide instructions for sodium and potassium channels cause LQTS, and
the most common genes are KCNE1, KCNE2, and SCN5A. With no structural changes in
the heart, the key diagnostic tool is the ECG (Electrocardiogram), which typically shows
the prolongation of the QT interval. In some cases, individuals may be “gene-positive,
phenotype-negative,” meaning these individuals carry a known gene mutation but do not
show signs or symptoms of the condition (Basavarajaiah et al., 2007).
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In addition, Short QT (SQT) syndrome also affects the QT interval and can be
associated with arrhythmias and SCD. Symptoms including dizziness, syncope, and/or
cardiac arrest can occur anytime from early infancy to old age. Genetic changes in
potassium channel genes, KCNH2, KCNJ2, and KCNQ1, cause SQTS. Much less is
known about this condition, as only a few hundred individuals have been identified
worldwide (Napolitano et al., 2012).
Another channelopathy, Brugada syndrome, affects the ST segments on the
patient’s ECG. This condition leads to ventricular arrhythmias, and if left untreated can
cause fainting, seizures, difficulty breathing, and sudden cardiac death. Cardiac events
most often occur during rest or sleep, but are also known to occur during exercise
(Napolitano et al., 2012). Signs and symptoms of Brugada syndrome typically become
apparent in adulthood, but can occur from early infancy to late adulthood. This condition
may explain some cases of SIDS, and cases of sudden death before the age of 40 years
(National Library of Medicine, 2016).
The frequency of Brugada Syndrome is estimated to affect 1 in 2,000 individuals
worldwide, with a higher prevalence in Asian ancestries. Brugada Syndrome is also eight
to ten times more common in men than in women due to the synergistic affects of
testosterone. The most commonly mutated gene in Brugada Syndrome is SCN5A, which
reduces the flow of sodium ions into heart muscle cells (National Library of Medicine,
2016). This condition is typically treated with strict exercise guidelines regarding
disqualification from competitive sports that may lead to traumatic injury or loss of
consciousness due to the higher likelihood of cardiac event during sleep, rest, or loss of
consciousness (Maron et al., 2015).
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Other conditions that may cause SCD include but are not limited to familial dilated
cardiomyopathy (DCM), catecholaminergic polymorphic ventricular tachycardia
(CPVT), and left ventricular non-compaction cardiomyopathy (LVNC). These
cardiovascular syndromes are all inherited conditions that are associated with
considerable risk of cardiac events (Maron et al., 2015). A comprehensive table
describing the genetics, inheritance pattern, and prevalence of these conditions can be
found in Appendix E.
1.2 Genetics of Sudden Cardiac Death
Genetic testing for these congenital heart diseases has improved dramatically in
the past five to ten years, and cardiac multigene panel testing is now widely available for
symptomatic patients. Family members of a patient with a history of SCD or with
significant symptoms are encouraged to seek genetic counseling for potential genetic
testing when a known mutation has been identified in one close family member
(Ormondroyd, Oates, Parker, Blaire, & Watkins, 2014). Approximately 5% to 15% of
cardiac arrest victims fail to show evidence of structural abnormalities at the time of
autopsy. If the individual is then genetically diagnosed at autopsy with idiopathic left
ventricular fibrillation, recommendations for testing for the specific mutation are
communicated to close family members. This fact, in addition to incomplete penetrance
and variable expressivity of the various genotypes, highlights the importance of genetic
testing for all family members at risk (Napolitano et al., 2012).
Penetrance is described as the proportion of people with a particular mutation who
exhibit signs and symptoms of a genetic disorder. Variable expressivity refers to the wide
range of signs and symptoms that can manifest in different individuals with the same
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genetic condition. Variable expressivity and reduced penetrance result from a
combination of environmental, genetic, and lifestyle factors. Most of the
cardiomyopathies and channelopathies previously described are known to show variable
expressivity and reduced penetrance, with some family members with the mutation
showing minimal or no symptoms. This often presents as a challenging case with
seemingly no suggestive family history. Thus, genetic counselors offer a closely targeted
family history intake, with focused questions about a known set of possible phenotypic
symptoms within a three-generation family history.
Families with inherited cardiac conditions will have affected individuals who
showed signs or symptoms at completely different ages. Symptoms may also vary among
family members with the same mutation including chest pain, shortness of breath,
syncope, palpitations, cardiac arrest, and those reporting with no symptoms. This is
especially seen in families with HCM, making it difficult to predict genetic testing
outcomes for family members (Cirino & Ho, 2014). Since some affected individuals
show no symptoms, genetic testing of unaffected close family members is a critical step
in making a genetic diagnosis when a deleterious mutation has been identified in a
clinically affected individual.
ARVC is an autosomal dominant condition with age-related penetrance and
significant variable expressivity. This cardiomyopathy in addition to HCM varies in the
age of onset and clinical presentation for each individual, sometimes even with the same
familial mutation. A review from 2015 states that exercise plays a major role in disease
penetrance and risk for SCD in ARVC (James, 2015). When analyzing a possible
inheritance pattern within a three-generation family history, the age of onset is critical to
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assess for possible physical manifestation and cardiac events in family members. This
challenging task is typically performed by a genetic counselor.
Similarly, another publication by (Earle et al., 2014) demonstrated that small
changes in arrhythmia genes modify the risk of cardiac events and SCD in long QT
syndrome. They identified two small changes (single base DNA misspellings called
single nucleotide polymorphisms, or SNPs) in both of the NOS1AP and KCNQ1 genes
that are associated with an increased risk for arrhythmia. Several other SNPs were
suggested to show both positive and negative associations with QT length on an ECG
(Earle et al., 2014). Even the smallest changes in arrhythmia genes can have critical
phenotypic effects on patients, stressing the importance of personalized genetic
counseling for each individual family and each genetically diagnosed patient based on
their unique genetic change.
Counseling families effectively on the unique genetic cause of cardiovascular
disease in their family, the risk of SCD or other complications, specific triggering events,
and medical management is challenging. Therefore, appropriate knowledge in genetics
and the ability to communicate that information to patients in an understandable manner
is critical to provide relevant healthcare for each individual. Appropriate management of
each case is dependent on the specific genetic cause of the specific cardiovascular
condition, as well as the environmental factors that could contribute to that individual’s
risk.
1.3 The Bethesda Guidelines and Current AHA/ACC Exercise Recommendations
Despite the health benefits that typically result from regular exercise in most
individuals, the small subset of individuals who are at risk for SCD must weigh the
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possible risks that come with exercise. Many individuals diagnosed with HCM, ARVC,
LQTS types 1 and 3, SQT Syndrome, Brugada syndrome, and other similar diagnoses are
at an elevated risk for arrhythmias, syncope, and SCD at times of strenuous physical
activity (Sheikh et al., 2015; Napolitano et al., 2012). A significant amount of research
has been reported on SCD in competitive athletes, and studies have determined that
sudden arrhythmic death syndrome (SADS) was the most prevalent cause of death at
young ages in these athletes. Specifically, a study performed between 1994 and 2014 of
357 young competitive athletes who died suddenly showed that 42% of the cases were
due to SADS: 13% due to ARVC; 6% due to HCM; and 13% due to idiopathic left
ventricular hypertrophy (Finocchiaro et al., 2016). In another study performed on 842
young competitive athletes with autopsy-confirmed cardiovascular diagnoses through the
U.S. National Registry of Sudden Death in Athletes, HCM was the most common
diagnosis, occurring in 36% of patients; with ARVC diagnosed in 13%; and LQTS
diagnosed in 7% of the athletes (Maron et al., 2016b).
With recent research and new knowledge about the gene-specific etiologies of
hereditary cardiovascular conditions, many state health departments and school-based
athletic programs have implemented cardiac screening programs as a requirement for
competitive athletic eligibility in schools. Screenings include an electrocardiogram
(ECG), which can detect ARVC, LQTS, SQT syndrome, and some cardiomyopathies
(Caselli, Attenhofer Jost, Rolf, & Pelliccia, 2015). Recent literature has debated whether
or not pre-participation screenings are over-diagnosing individuals, but others have
argued that this type of screening of young athletes has allowed detection of an increasing
number of true diagnoses before a cardiac event has occurred in an individual (Maron et

8

al., 2004). If a positive screen is further diagnosed as a syndrome at risk for SCD as a
common possible outcome, medical management will be enforced (Maron et al., 2016b).
In many cases, guidelines state that these individuals should be disqualified from
competitive sports and should make lifestyle changes in their exercise activities.
The Bethesda Criteria is a set of guidelines and recommendations that have been
released in three revisions, all sponsored by the American College of Cardiology (ACC).
The most recent document was released in 2005 for the trained athlete with an identified
cardiovascular abnormality that significantly increases the risk for SCD. Specifically, the
2005 criteria provide recommendations regarding eligibility for competition in organized
sports (Pelliccia et al., 2008). This set of guidelines is intended to be used as a tool for
physicians and medical professionals when presenting medical management
recommendations to a newly diagnosed patient. The 2005 revision was fueled by
advancements in medical management and the SCD awareness in the community and
public media.
Within the Bethesda Criteria, pre-participation screening is discussed for college
and high school athletes. The report explained the recommendations for testing options
such as echocardiography, electrocardiography, and other forms of imaging (Maron et al.,
2004). The majority of the guidelines are somewhat specific by basic etiology of cardiac
diseases. Their associated recommendations are based on information known in 2005,
now more than ten years in the past. For example, the guidelines state that athletes with
hypertrophic cardiomyopathy should be excluded from most competitive sports, with the
exception of class 1A sports, which include billiards, bowling, and golf. Similarly,
athletes with arrhythmia disorders including LQTS and SQT syndrome are to receive
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strict recommendations that include restriction of all sports except for 1A category
activities. A diagnosis can differ depending on age, genetics, and presence or absence of
an ICD or pacemaker (Pelliccia et al., 2008). The Bethesda Guidelines are often thought
by some cardiologists to be overly strict and non-specific to the patient.
In 2015, the American College of Cardiology (ACC) and American Heart
Association (AHA) released a scientific statement regarding eligibility and
disqualification recommendations for competitive athletes with cardiovascular
abnormalities (Maron et al., 2015). The main intention of these organizations was to
present a readily usable set of recommendations and guidelines addressing criteria for
eligibility for and disqualification from organized competitive sports due to high risk
cardiovascular conditions in hopes of promoting the health and safety of young athletes
by preventing sudden death in the young. As an update to the 36th Bethesda Conference,
the present document serves to adapt to new technology, motivations, and awareness for
athletes at risk for SCD (Maron et al., 2015).
The 2015 guidelines classify sports based on their static and dynamic components.
See Appendix D for ACC classification of sports activities. The static component is
related to level of endurance, or the percentage of a maximal voluntary contraction of any
muscle in the body. Sports with a higher static component include intense sports such as
rock climbing and water-skiing, each requiring longer muscle contractions. The dynamic
component includes how regularly the large muscle groups of the body are being used.
More dynamic sports examples include boxing and rowing. In the document, sports are
also classified by their intensity to increase the risk of intracranial hemorrhage and/or loss
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of consciousness, which is important for individuals undergoing treatment with an
anticoagulant agent (Maron et al., 2015).
The second section addressed pre-participation screening in competitive athletes.
Screening is recommended to include personal medical history and family history, plus a
physical exam. Any suspicious findings may result in further testing, including a stress
test, ECG, or echocardiogram. The authors noted that universal ECG testing might be
considered in small high school and college populations. Large-scale general cardiac
screening with ECGs at universities and public events is not yet recommended (Maron et
al., 2015).
The 2015 updated guidelines specified recommendations by type of condition,
including cardiomyopathies, congenital heart disease, valvular heart disease,
hypertension, aortic diseases, coronary artery disease, channelopathies and
arrhythmogenic conditons. The cardiomyopathy task force focused on HCM and ARVC,
and recommended that those individuals with symptomatic HCM should not participate
in most competitive sports, with the exception of low intensity activities (Class IA
sports). Genotype-positive phenotype-negative HCM patients could participate in more
competitive sports (Class IIa), especially in the absence of HCM-related sudden death in
the family history. All patients with HCM were encouraged to consider pharmacological
agents such as beta-blockers to control cardiac-related symptoms (Maron et al., 2015).
Much stricter guidelines were recommended for ARVC, with the 2015
recommendations stating that anyone with a definite or even possible diagnosis of ARVC
should not participate in most competitive sports. Low intensity sports (Class IA) are an
exception. In addition, ICDs should not be placed in athletes with ARVC or HCM for the
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sole purpose of participating in high-intensity sports because of device-related
complications (Maron et al., 2015).
The 2015 recommendations combined all channelopathies into one set of
recommendations. For symptomatic athletes with any suspected or diagnosed
channelopathy condition, the ACC/AHA experts recommended that athletes be restricted
from all competitive sports until a comprehensive evaluation has been completed.
Asymptomatic athletes, or those who are genotype-positive and phenotype-negative,
could be allowed to participate in all competitive sports. This is only if precautionary
measures are taken into consideration, including avoidance of QT prolonging drugs in
patients. Electrolyte and rehydration replenishment was recommended as critical medical
management, and the implementation of an emergency action plan, including access to an
automated external defibrillator (AED), was included as precautionary measures that
should be taken (Maron et al., 2015).
For channelopathies, the updated guidelines state that previously symptomatic
patients who have been asymptomatic while on treatment for at least three months with
either medication or an ICD may be eligible for competitive sport participation. This is
true for all Class IIb sports except for swimming (Maron et al., 2015). Patients should be
closely monitored and followed up by their medical staff throughout participation.
The final portion of the updated guidelines included recommendations regarding
drugs and performance-enhancing substances, emergency action plans, SCD triggered by
innocent blows to the precordium, and legal aspects of medical eligibility and
disqualification (Maron et al., 2015). When considering the entire set of guidelines,
nowhere in the document is there a task force directive on how these recommendations
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should be communicated to patients. Similarly, the recommendations do not state which
medical professionals are responsible for communicating these guidelines to patients
(Pelliccia et al., 2008).
The 2015 ACC/AHA recommendations only apply to competitive athletes in
competitive sports (Maron et al., 2016a). No defined guidelines for diagnosed patients
who are non-competitively active have been published to the best of our knowledge,
which is troublesome since the athlete’s heart is under notably different stress than those
active individuals without a high physical demand during their exercise activities. This
difference may necessitate a new set of guidelines for the typical individual who wishes
to maintain a healthy exercise regimen after a diagnosis of a genetic cardiovascular
condition that includes susceptibility to SCD.
1.4 Impact of a Diagnosis on Psychosocial and Activity Lifestyle Changes
Previous research has shown that a diagnosis with a serious cardiac disease can
lead to sensitive psychosocial effects in patients (Rosman et al., 2014). A study
performed on adolescents with heart disease showed that individuals present with a
variety of self-perceptions regarding behavioral and health-related quality of life
(Mussatto et al., 2014). Another study looked more closely at inherited cardiac conditions
and psychosocial implications of pre-symptomatic genetic testing (Ormondroyd et al.,
2015). This study provided rich data that supported the perceptions of a positive result,
and the difficulties of requiring major lifestyle changes. In addition, these authors
determined that families might require more psychosocial support or counseling about
genetic test information and medical management recommendations in order to alleviate
some emotional challenges and physical limitations that they may face.
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Despite the evolution of the Bethesda Criteria in 2015 and support groups for
SCD, research studies have shown significant psychosocial impacts on athletes after they
have received a potentially lethal cardiac disease diagnosis (Asif et al., 2015a). These
authors reported patients’ feelings of avoidance and hyper-arousal about their conditions.
The highest risk individuals for significantly negative psychosocial impact included those
who were permanently disqualified athletes. Those who were able to participate in certain
levels of activity had less emotional impact, suggesting the potential effects of the strict
Bethesda guidelines on patients who are not competitive athletes and who may have a
less serious diagnosis, which still limits their exercise practice. The authors concluded
that these disqualified athletes tended to avoid conversations regarding their diagnosis
and may require further emotional and informational support than is currently being
provided to them.
Another similar study looked at the role of medical professionals in an athletic
patient’s diagnosis of a potentially lethal cardiac disease. The risk for psychosocial
distress was increased for those with higher level of competition, those with complete
restriction from activity, and athletes with unanticipated outcomes or failed procedures in
their medical management. An important conclusion from this study was that medical
professionals typically lacked emotional support counseling skills and clarity in their
information regarding procedures and medical management (Asif et al., 2015b). Minimal
research exists that studies the psychosocial effects of a lethal cardiac disease diagnosis
on non-competitively exercising adults.
The implantable cardioverter defibrillator (ICD) offers protection against SCD by
terminating potentially lethal arrhythmias (Maron & Maron, 2016c). ICDs have been
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used for both primary and secondary prevention in patients with cardiomyopathies,
arrhythmia conditions, and previous history of unexplained syncope. Primary prevention
is defined as ICDs for those who are at risk for a first arrhythmia. Secondary prevention
applies to those who have previously experienced an arrhythmia or have experienced
cardiac arrest without an ICD at that time (Carroll & Arthur, 2010). Risks associated with
ICDs can include inappropriate shocking when unnecessary as well as delayed shock
during cardiac arrest. Despite their limitations and risks, ICDs have allowed patients who
would have been previously limited from all activities to take part in moderate exercise
practices (Gaba et al., 2016).
Carroll and Arthur (2010) studied the psychosocial effects of patients receiving
their first ICD for both primary and secondary prevention of SCD. The researchers
measured outcomes of levels of anxiety, uncertainty, and optimism before and after the
implant. Individuals experienced significant uncertainty before receiving the ICD.
Optimistic disposition and normal anxiety were common themes also identified before
the ICD was implanted. However, anxiety levels measured higher in secondary
prevention patients than in primary patients who had not yet experienced a cardiovascular
episode due to their condition. Overall, these authors described an emphasis on the
psychosocial and informational needs of these patients with new ICDs. They concluded
that patients with ICDs should be adequately educated on the risks, expectations, and
functions of the device, especially prior to exercise or activity.
A consistent theme across many of these publications that focus on athletes was
that competitive individuals experience the most negative psychosocial impact when they
are disqualified from their desired sport. The fact that their biggest stress-relieving
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activity, passion, or even career is taken away from them is heartbreaking for most.
Research has shown that some athletes choose to continue participating in sports both
with and without ICDs. These patients mostly showed low rates of cardiac events and no
deaths. Minimal research has been published on how similar exercise restrictions on
individuals who are not competitive athletes can emotionally and physically affect them.
Adults who have a typical exercise practice but do not participate competitively may
experience different psychological effects after a diagnosis (Johnson & Ackerman, 2012).
A potential lethal cardiac disease diagnosis that is associated with SCD is psychologically
traumatic for any patient, and requires adequate counseling and guidance to provide the
safest and most adequate medical management and support for each individual patient.
1.5 The Effectiveness of Current Guidelines and Exercise Recommendations
As previously stated, the exercise recommendations for athletes remain strict,
conservative, and non-personalized. In most cases, adherence to the Bethesda Criteria
results in disqualification from all competitive sports and activities. To our knowledge,
no current guidelines exist for average active adults at risk for SCD who exercise at or
below the suggested 150 minutes each week as recommended by the AHA to benefit
one’s health and well-being (Cheung, Laksman, Mellor, Sanatani, & Krahn, 2016). Many
patients at risk for SCD find it critical to balance the benefit of physical activity in
cardiovascular disease with their risk for SCD. Previous research by Canadian healthcare
providers have reported the recommendations that they share with patients (Roston, De
Souza, Sandor, Sanatani, & Potts, 2013). These findings indicated that the majority of
cardiac care providers who participated in the study only partially communicated current
exercise recommendations. Physical activity recommendations for many of the congenital
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physical and electrophysiological heart defects varied considerably. This valuable study
supports the hypothesis that the medical professionals are practicing inconsistent
communication of essential medical management information to their patients. Thus,
further research is needed on patient experience and understanding of their exercise
recommendations and medical management safety.
Research in genetic causes of these cardiovascular conditions has improved
tremendously, and previously generalized diagnoses are now categorized by the specific
mutation within a given gene or the genetic etiology of each individual case. Because of
this, each patient should have his/her own personalized medical management
recommendations based upon the physical makeup which includes the specific genetic
etiology of disease, age, weight, ethnicity, environment, and other relevant factors such
as family history.
A recent research study of the 2005 Bethesda guideline limitations in exercise
restrictions for patients with inherited cardiac conditions stressed the impracticality and
ineffectiveness of such rigid guidelines. With such heterogeneous syndromes,
individualized patient-centered appraisal and care was recommended for the future. New
general guidelines through the 2015 AHA and ACC stressed the importance for
movement towards personalized medicine in cardiology (Hammond-Haley, Patel,
Providencia, & Lambiase 2016).
The decision to continue or discontinue an exercise practice is ultimately up to the
patient or their family in the pediatric age group. Their decision is influenced by factors
including past experiences, personality type, family or peer influence, love for activity,
and understanding of medical recommendations. A research study of athletes with LQTS
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showed that 37% of patients chose to remain in competitive athletics. Some of these
patients had ICDs, and it is important to note that none of these athletes had a sportrelated cardiac event. A conclusion from this study supported that current guideline
recommendations for disqualification may be excessive for disease (Johnson &
Ackerman, 2012). Since this study focused on competitive athletes, it may be true that
even these guidelines may also be excessive for non-competitive active adults who
experience much less physical stress than athletes.
Conclusions from these studies reflect that current recommendations apparently
are not adequately or consistently communicated, enforced, or followed by at-risk
individuals. The field of cardiovascular SCD conditions needs updated guidelines that
focus more individually on exercise recommendations appropriate for each specific
condition, and could benefit from a personalized medical management interpretation that
is unique to each individual case. Older guidelines that seem overly rigid and strict may
be too excessive, and could lead those at risk for SCD to take part in activities that could
lead to cardiac arrest. The current state of knowledge in 2017 should bring together the
multiple factors that influence exercise management for these diagnoses, including genespecific causes and genotype-phenotype correlations; cardiac research; technologies such
as ICDs and pacemakers; and the availability and knowledge of cardiovascular genetic
counselors to update guidelines that could then be effectively communicated to all
patients at risk for SCD.
1.6 Role of a Genetic Counselor in Cardiovascular Genetics
The role of a genetic counselor has been clearly described. The Genetic Alliance
(Genetic Alliance, 2009) has identified genetic counselors as a central resource of
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information about genetic disorders for patients, other healthcare professionals, and the
general public. In general, a genetic counseling session aims to increase the patient’s and
family’s understanding of a genetic condition, including management and testing options.
Genetic counselors are trained to identify the psychosocial triggers of a person diagnosed
with a genetic condition to help those patients cope with potential implications such as
future possible outcomes, and to reduce overall anxiety due to the diagnosis (Genetic
Alliance, 2009).
All genetic counselors are trained to develop exceptional skills in patient education
and psychosocial processes. These skills are performed in a variety of concentrations
including but not limited to pediatrics, cancer, cardiovascular, prenatal, and neurology
specialty clinics. Genetic counselors are expected to educate patients on the benefits,
risks, limitations, and potential outcomes of genetic testing; interpretation of results and
their implications; medical management recommendations; and outside resources for
supporting the patient and family. They also have unique skills to interpret and manage
the psychosocial elements that may arise in a session when a positive genetic test result is
revealed (Uhlmann, Schuette, & Yashar, 2011).
Cardiovascular genetics is particularly interesting for genetic counselors. Genetic
testing is typically aimed at reducing uncertainty, but cardiovascular genetics can leave
patients feeling uncertain about their risks for cardiac events, medical management, and
risk for family members if those implications are not fully addressed. Patients have
reported experiencing psychological distress in regards to not only the diagnosis, but also
how to manage that diagnosis (Ackerman et al., 2011). Various research studies have
shown the significant elevated distress and negative psychosocial impact of a positive
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genetic test for a condition that increases risk for SCD (Mussatto et al., 2014; Asif et al,
2015).
Other genetic counseling concentrations, such as cancer genetic counseling, have
clear testing and management guidelines that counselors use when educating patients
about a positive test result. These include the NCCN guidelines for management of an
individual with a positive BRCA1 or BRCA2 test result, or of an individual who has been
genetically diagnosed with Lynch syndrome as a hereditary type of colon cancer, as well
as similar guidelines from professional organization such as The American Society of
Clinical Oncology (ASCO) and the America College of Obstetrics & Gynecology
(ACOG). Similar management guidelines exist for cardiovascular genetic testing through
the American Heart Association and Heart Rhythm Society; however, no definitive
structure exists for cardiovascular genetic counselors to discuss topics such as exercise
management which today are beyond the topics of genetic testing and implications of
genetic test results for the patient and the patient’s family (Ackerman et al., 2011). All
genetic counselors have the skills and expertise to address the psychosocial implications
that come with cardiovascular genetic counseling, including the patient information and
implications about exercise recommendations if those recommendations exist for the
specific SCD condition.
This study addresses the needs of non-competitive active adults who have been
diagnosed genetically with an SCD condition that may call for restriction of their exercise
activities. We proposed that most of these patients would be less than satisfied with the
exercise recommendations that they were given, as no clear guidelines yet exist for
reconciling a gene-specific SCD condition with personalized exercise recommendations
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for this group of active adults. The study could result in a call for exercise guidelines as
medical management guidance to be formally included within the domain of
cardiovascular genetic counselors, which could benefit this class of patients with genetic
conditions.
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Chapter 2
Exercise Recommendations for Active Adults at Risk for Sudden Cardiac Death:
“Can I Continue to Exercise?”1
Section 2.1 Abstract
Sudden arrhythmic death syndrome (SADS), is due to genetic conditions
associated with cardiac ion channelopathies and cardiomyopathies. Many of these
conditions have exercise guidelines regarding eligibility and disqualification
recommendations for competitive athletes through the American Heart Association and
the American College for Cardiology. This study investigates how medical professionals
communicate these exercise recommendations to patients, and in turn, how well patients
understand these recommendations. The study also explores motivations for either
continuing or discontinuing an exercise practice after a diagnosis. A questionnaire was
distributed through cardiac disease-focused support groups and organizations. Data from
67 individuals with a SADS condition were analyzed for possible associations and
significant differences. Results demonstrated that intensity of exercise on a 1 to 9 scale
decreased from 4.9 to 3.3 after a diagnosis (p < .01). Time spent exercising decreased
from 204 minutes per week to 142 min/week after a diagnosis (p < .01). Patients were
significantly more likely to decrease activity intensity when they felt confident with the
communication of their exercise recommendations and how well they understood them.
________________________________________________________________________
1

Baker, K., Walker, P., Asif, I., & Hill-Chapman, C. Manuscript to be submitted to Circulation, 2017.
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This study showed that individuals felt poorly informed regarding their exercise
recommendations and often take on heavy emotional burdens due to restrictive
guidelines. The respondents widely expressed that quality of life is an important factor in
their decisions about exercise, and that continuing exercise is a major component of a
healthy lifestyle despite risks associated with SADS. Involving genetic counselors in the
discussion of exercise guidelines is recommended to address the psychosocial outcomes
of a recent diagnosis. This addition to the management of individuals with a SADS
diagnosis is likely to increase awareness of how exercise recommendations are managed
and how well patients understand that their personalized exercise plan will promote a
safer healthcare management plan for each patient.
Section 2.2 Introduction
Sudden arrhythmic death syndromes (SADS) are genetic heart conditions that can
cause sudden cardiac death (SCD) in individuals where a structural heart defect may or
may not be present. Some of the genetic cardiovascular diseases include but are not
limited to cardiomyopathies and chanelopathies (Sheikh et al., 2015). Cardiomyopathies
refer to diseases of the heart muscle, where muscle tissue becomes thickened and rigid,
making the heart weaker and prone to arrhythmias and even SCD. Channelopathies are
diseases that result from the dysfunction of ion channels located in the membranes of
cells, and specifically in cardiac tissue. Channelopathies can lead to irregular heart
rhythms, syncope, arrhythmias and SCD. LongQT and Brugada syndrome are two of the
more common ion channelopathies associated with a risk of SCD (Napolitano et al.,
2012).
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Genetic testing for these heart conditions associated with SADS has improved
dramatically, and multigene panel testing is available for symptomatic patients or those
with a family history. Since many of these conditions may show no clinical signs on
echocardiogram (ECG) or echocardiography, genetic testing has become the gold
standard for diagnosing these conditions. Patients at risk are encouraged to seek genetic
counseling for analysis of family history and pre-test counseling when indicated
(Ormondroyd et al., 2014). Since both cardiomyopathies and channelopathies display
reduced penetrance and variable expressivity, not everyone who carries a mutation will
develop symptoms (Cirno & Ho, 2014). In addition to a genetic and clinical diagnosis,
the patient’s age, sex, and lifestyle choices influence the risk for developing symptoms
(Ackerman et al., 2011).
Despite health benefits that typically result from exercise in most individuals, the
subset of individuals who are at risk for SCD must weigh the health risks that come with
exercise. Research shows that individuals at risk for SADS may have a higher risk for an
adverse cardiac event during exercise (Maron et al., 2016b). In 2015, the American
College of Cardiology (ACC) and American Heart Association (AHA) released a
scientific statement regarding eligibility and disqualification recommendations for
competitive athletes with cardiovascular abnormalities. This statement presented a readily
usable set of recommendations addressing criteria for participation or disqualification
from organized competitive sports due to high-risk cardiovascular conditions in hopes of
promoting the health and safety of young athletes by preventing SCD (Maron, et al.,
2015).
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The 2015 statement classifies sports based on their static and dynamic
components, and includes activity recommendations and medical management guidelines
specific to each cardiac condition. See Appendix D for ACC sport classification. This
document targets a small portion of the entire population at risk for SADS, and there are
currently no guidelines that are specific to the larger population of active adults who are
non-competitive athletes.
Previous research has shown that a diagnosis with a serious cardiac disease can
lead to sensitive psychosocial effects in patients (Rosman et al., 2014). Presently more
commonly used in athletes is the ICD, which is a piece of technology that offers
protection against SCD by terminating potentially lethal arrhythmias (Maron & Maron,
2016c). The ICD can benefit psychosocial impact by making exercise guidelines less
strict, but can also increase patient anxiety due to fear of shock during a cardiac event and
even inappropriate shocking (Gaba et al., 2016).
As stated previously, to our knowledge no current formal exercise guidelines exist
for average active adults at risk for SADS. However, many patients at risk for SADS find
that balancing the benefit of physical activity with their risk for cardiac events is critical
to their well-being. Previous research in Canada surveyed Canadian cardiac healthcare
providers who indicated that they only partially implement current exercise
recommendations (Roston et al., 2013). Another study looked at competitive athletes with
LQTS, and found that 37% of those individuals chose to remain in competitive sports
despite their diagnosis (Johnson & Ackerman, 2012). These studies have led to
conclusions that current exercise recommendations may not be adequately communicated
or are not followed by a significant portion of these at-risk individuals.
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No currently recommended guidelines exist stating which medical professionals
should be sharing exercise recommendations with patients. After a SADS diagnosis,
medical management includes not only exercise guidelines, but also likely includes a
psychosocial burden. Other information such as potential risks for family members,
patient education on the etiology of the disease, and further medical management are
critical components to also be addressed at the time of diagnosis. Recognizing that these
are all topics that require an ample amount of time with patients, perhaps the medical
community should seek additional healthcare team members to assist with the diagnosis
and translating the full implications of that diagnosis for the patient and her/his family.
Genetic Counselors are individuals who assess individual or family risk for a
variety of inherited conditions including SADS conditions (Genetic Alliance, 2009).
Cardiovascular genetic counselors are growing in numbers, with more genetic counselors
present in cardiology clinics as their fulltime responsibility and others interacting on a
regular basis with cardiologists who refer their patients to specific genetic counselors
with cardiovascular training and expertise. Cardiovascular genetic counselors may be
appropriate individuals to address SADS medical management, exercise
recommendations, and the psychosocial impacts that may follow a diagnosis of a genetic
cardiac condition that increases the patient’s risk of SCD (Ackerman et al., 2011).
Regardless of which medical professionals are communicating medical
management and exercise recommendations for those at risk, increased awareness of how
exercise recommendations are being communicated to patients and how well patients
understand their medical management should promote a safer and more personalized
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healthcare plan for patients, while improving the psychosocial outcomes of a recent
diagnosis.
Section 2.3 Materials and Methods
This research study collected quantitative and qualitative data from active adults
who have a genetic condition that puts them at risk for SCD. Participants were recruited
through condition-specific support group organizations and Facebook groups targeted for
families affected by the previously described conditions. Individuals over the age of 18
who have had a diagnosis associated with increased risk of SCD or sudden arrhythmic
death syndrome (SADS) and could comprehend the medical and technical information in
the questionnaire were eligible to participate in this study.
An invitation to participate (see Appendix A) as well as a link to the survey was
hosted on surveymonkey.com, with access to the survey distributed through several
venues. The SADS Foundation and Hypertrophic Cardiomyopathy Association were
contacted via email to explain the purpose of the study and inquire if they were willing to
invite their members to participate. These organizations were willing to invite their
members to participate and did so via their respective electronic mailing lists. In addition,
a link to the survey (see Appendix B) was posted on various Facebook groups throughout
September, 2016, and was available until December 31, 2016.
The questionnaire consisted of multiple choice and open-ended questions that
investigated demographic information for each of the participants. It also explored the
diagnostic process; pre and post-exercise activity including length of time and type of
sport or activity; and number of cardiac events. Other questions queried topics regarding
ICDs, medication, and confidence in understanding of guidelines. Open-ended questions
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explored the psychosocial affects following a diagnosis and discussion of appropriate
post-diagnosis activities.
Quantitative analysis was performed with SPSS software, version 24, using a
dependent samples analysis technique to assess trends before and after a diagnosis. For
categorical dependent variables, non-parametric analysis techniques were employed,
including logistical regression, test of marginal homogeneity, and chi-square test for
independence. For continuous quantitative dependent variables, repeated measures
analysis of variance (ANOVA) was used to assess for statistical significance, set at
p = .05 or less. Descriptive statistics were calculated by Excel software for percentages
and basic information.
Qualitative questions from the survey were separately coded by two independent
individuals (first and second authors) using grounded theory methods. After individual
coding, findings were discussed to reach consensus on basic themes that emerged from
the qualitative responses. This research study was approved by the Institutional Review
Board, Office of Research Compliance, of the University of South Carolina, Columbia,
SC, in June, 2016.
Section 2.4 Results
Eighty-seven individuals participated in the survey. Sixty-seven individuals met
criteria to be included in the study and completed the survey. Respondent demographics
are displayed in Table 2.1. Of the 67 respondents, 17 (25%) were male and 50 (75%)
were female. The mean age of the participants was 48 years, with a range of 18 to 72
years of age. The majority of respondents were Caucasian (n = 61, 91%) and had
completed at least some college (n = 55, 82%). The majority of participants had been
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diagnosed with HCM (n = 34, 51%), and 17 individuals had been diagnosed with LQTS
(25%), 15 with Brugada syndrome (22%), and one with LVNC (2%). The average age at
time of diagnosis was 39 years.

Table 2.1
Demographics
Frequency
(n)

Percentages
(%)

Gender
Male
Female
Ethnicity
Caucasian
Asian/Pacific
Islander
African American
Hispanic/ Latino
Mediterranean
Highest Level of Education
Did not complete
High school
High school
diploma or GED
Some college
Associate’s Degree
Bachelor’s Degree
Some Graduate
School
Graduate Degree
(Masters, PhD, MD,
etc.)
Type of Diagnosis
Hypertrophic
Cardiomyopathy
Long QT Syndrome
Brugada Syndrome
LVNC
Do you have an ICD?

17
50

25%
75%

61

91%

4
0
0
2

6%
0%
0%
3%

3

5%

7
9
8
20

11%
14%
12%
31%

4

6%

14

22%

34
17
15
1

52%
26%
21%
1%

Yes

30

44%

No

37

55%
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Statistical analysis was performed using SPSS software. Statistical significance was set at
p = .05 or less. We analyzed minutes of activity before and after a diagnosis, and type of
activity before and after a diagnosis using paired T-Tests. Activity level was coded on a
ranking scale of one unit to nine units (one being least intense level of activity, and nine
being most intense) using the static/dynamic activity chart from the AHA guidelines
(Maron et al, 2015). The mean activity intensity before a diagnosis was 4.90 units (SD =
2.41), and after a diagnosis was 3.32 units (SD = 2.44) (p < .01). The mean minutes of
exercise before a diagnosis was 204 minutes per week (SD = 178.1), and was 142 minutes
per week (SD = 127.5) after a diagnosis (p < .01).
Repeated measures ANOVA test compared the difference in activity intensity before
and after a diagnosis and the difference in minutes of exercise before and after a diagnosis
against the following four variables:
•

the confidence with participants’ understanding of exercise recommendations
(Likert Scale 1-5). See Figure 2.1;

•

satisfaction with the medical professional’s communication of exercise
recommendations (Likert Scale 1-5). See Figure 2.2;

•

presence or absence of ICD; and

•

educational level by category.
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18
16
14
12
10
8
6
4
2
0
Not at all

Somewhat

Moderately

Mostly

Extremely

Figure 2.1. Confidence in Understanding Exercise Recommendations
(n = 65)

18
16
14
12
10
8
6
4
2
0
Not at all

Somewhat

Moderately

Mostly

Extremely

Figure 2.2. Satisfaction with Communications about Exercise Recommendations.
(n = 61)
Table 2.2 displays the statistical outcomes of eight comparisons, three of which were found
to be statistically significant. Individuals who were more confident with their
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understanding of exercise recommendations were statistically significantly more likely to
decrease activity intensity after a diagnosis (p < .01). Individuals who were more satisfied
with the communication of exercise recommendations by medical professionals were
statistically significantly more likely to decrease exercise intensity after a diagnosis
(p < .01). Those with a higher level of education exercised for fewer minutes after a
diagnosis also showed statistical significance (p < .01). All other repeated measures
ANOVA comparison tests did not suggest statistical significance. See Appendix C for the
full ANOVA comparison statistics.

Table 2.2
ANOVA Comparisons
Change in
Exercise Intensity

Change in
Exercise Time
(min)

Confidence with Understanding of
Recommendations

p =.037**

p = .160

Satisfaction with communication of
recommendations

p = .042**

p = .205

Presence of ICD

p = .793

p = .075

Educational Level

p = .770

p = .039**

** = statistically significant

Analysis of qualitative data showed three major themes when evaluated
independently by two authors. These main themes were identified as follows:
•

Individuals feel poorly informed regarding their exercise recommendations;

•

Participants take on differing levels of emotional burden with exercise
recommendations; and

•

Exercise is a key component to quality of life in these active individuals.
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Individuals feel poorly informed regarding their exercise recommendations.
Some individuals were told to simply listen to their body when exercising and to be
aware of signs and symptoms when they appear. Many respondents felt conflicted on what
is considered enough exercise for a healthy lifestyle, and what is considered too much that
puts them at a higher risk for cardiac event.
Now that my 18 year old body is gone, I do feel the need to exercise, but it
is confusing. What is the max I can push myself to? I don't know, and I don't
think science knows either. I find that walking, and yoga are my safest bets.
Yoga has been strongly recommended by my Electrophysiologist not only
because he feels it's a safe level of activity, but for my emotional/mental
well being as well.

– 26yo female with LQTS

However, most respondents stated that they were never given exercise recommendations
and had to seek out advice on their own. “I had to ask for advice but nothing was offered.
Basically don't lift weights and no running. “ - 37yo female with HCM. Figure 2.3 shows
which resources patients utilized after a diagnosis to seek out exercise recommendations.
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Letters or resources from
doctor
Support group

11%

14%

33%

Bethesda Guidelines
AHA/ACC
Recommendations

23%

Family or Friends
Books

9%
5% 4%

Online Websites

1%
Other Resource

Figure 2.3. Resources Used by Patients to Better Understand their Exercise
Recommendations
*Other includes: “No resources used,” “Doctor,” & “Personal common sense”

A large segment of participants stated feeling confused, conflicted, and that they did not
understand guidelines.

Patients feel differing levels of emotional burden with exercise recommendations.
Many participants claimed to be devastated with their new diagnosis leading to
different exercise recommendations, while some others stated that they felt reassured with
their diagnosis with no comment about exercise recommendation. For some, exercise was
the main source of stress relief, and participants stated feeling shocked and surprised with
the information. Many also felt frustrated with the strict limitations and overwhelmed with
the recommendations that are not directed for non-competitive athletes.
“I was sad because I'm a pretty active person and also feeling that I wasn't fully
informed about other activities that I could do like hiking, climbing, yoga,
weight lifting and etc.”

- 27yo female with LQTS
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Participants admitted to living in fear of having a cardiac event during exercise.
That fear and the potential risk of leaving family members behind is an emotional
burden that comes for some with exercise recommendations.
“Anxious, easy to make excuses not to exercise. Very hard to stay
motivated, unsure of what safe boundaries are for me personally. Want to
fight against it as want to be healthy but also want to be here for my three
kids so not willing to risk much.”

- 48yo female with LQTS

Exercise is a key component to quality of life in these active individuals.
Multiple participants responded with willingness to accept risks of
exercising, as they wish to live life on their own terms by participating in activities
that they love the most. Many participants stated the importance of staying in shape
and exercising to keep their weight down to improve their overall health and wellbeing.
“I love exercise. It's always been a part of my life. I want to be fit and
healthy. I feel good when I exercise. I just don't push myself as hard as I
used to. It's a challenge finding the right balance.”
- 37yo female with Brugada syndrome
In addition, many feel that exercise is a stress reducer that works to better mental health.
By removing a stress reliever at a time where emotional burden is high, many individuals
feel even more emotionally impacted.
“My motivations for carefully resuming activity now are psychological.
Exercise helps me lowering my anxiety, it improves my tolerance to stress
and helps me trust my body and my meds again. I still stick to medical
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advice and I don't engage in competitive sports but I've realised I need to
stay active if I want to feel healthy.”

– 39 yo female with LQTS

Section 2.5 Discussion
From these results, we can conclude that both the intensity of activity and the time
spent exercising changed significantly after a diagnosis of a condition that puts a patient
at risk for SCD. However, our analysis shows a statistically significantly greater
difference in the intensity of activity after a diagnosis than in the time spent exercising. In
other words, participants were more likely to change their activity type than to change
their overall time spent exercising. We observed that those who were more confident with
their understanding of exercise were more likely to decrease their exercise intensity after
a diagnosis. Similarly, those who felt more satisfied with the communication of exercise
recommendations by medical professionals also were more likely to decrease their
exercise intensity after a diagnosis.
This important finding identifies key factors, which can motivate a patient to
change an exercise practice after a diagnosis. We measured that understanding and
communication of guidelines do not impact the time spent exercising. However, both
communication of and understanding of exercise recommendations can have a significant
impact on patient’s decision to decrease their exercise activity intensity. Thus, if patients
better understand guidelines that are communicated to them, they are more likely to
exercise at safer intensity levels or to choose entirely new exercise activities after a
diagnosis. These findings support the implication that improved patient care may be
possible through key communications about exercise alternatives and could lead to
perhaps more responsible medical management by the patient.
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We found that individuals with higher educational levels exercised for a shorter
time period after a diagnosis than they had before the diagnosis. This interesting finding
could potentially be explained by their higher education level and a better understanding
of exercise guidelines. This finding also highlights the importance of patient education in
the clinic, and the need to share the information with every patient in a way that she/he
can comprehend the information and take appropriate action to adapt their new exercise
regimen to their new diagnostic status. Discussions tailored to the patients’ education
levels could prevent those with less education from putting themselves at a greater risk
for cardiac events or SCD. Medical professionals must understand the patient’s ability to
understand the implications of a diagnosis and then adequately educate each patient to
ensure their understanding of appropriate exercise recommendations. Improving patient
understanding and building patient confidence with medical guidelines when they leave
the medical offices should help each patient correctly understand and utilize the
information that they have learned.
A recent diagnosis with exercise recommendations has the potential to have serious
psychological impact on any patient. Extensive previous research has been performed
with competitive athletes (Asif et al., 2015a; Asif et al., 2015b; Maron, B. et al, 2016a)
but minimal research, if any, has been published and made available as clear guidelines
for non-competitive active adults who simply wish to live an active and healthy life. Our
study demonstrated similar findings for non-competitive individuals, and that most of
them feel devastated, confused, depressed, sad, scared, and/or conflicted after a diagnosis
that requires new limitations on their exercise program but with no formal guidelines. We
found that non-competitive active adults felt emotionally burdened, similar to the feelings
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of competitive athletes in similar circumstances. Medical professionals should be aware
of this emotional burden when providing medical management guidelines, as patients do
not have to be exercising competitively to have a severe psychological impact.
Our results agreed with previous research regarding the emotional burden that
comes with a diagnosis, which requires exercise guidelines and limitations (Asif et al.,
2015a; Asif et al., 2015b). Most importantly, individuals stated strong feelings of
confusion, insecurity, and confliction in regards to the new exercise recommendations.
This is the first research study to our knowledge that focuses on the communication and
understanding of exercise recommendations for non-competitive active adults with a
diagnosis that puts them at risk for SCD or SADS, and how this information impacts their
decision to continue or discontinue an exercise practice. Our findings demonstrate that
additional research would likely benefit this medical field to ensure that patients and their
physicians are understanding appropriate exercise recommendations. Medical
professionals should adequately educate their patients about their exercise guidelines.
This can be done by ensuring an ample amount of time is available, by using teaching
skills at various educational levels, and by paying attention to the psychosocial burden
felt by the patient to provide more thorough care and better resources for patients.
Genetic counselors are beginning to enter the field of cardiology. They spend, on
average, about 45 to 60 minutes with each patient to complete risk assessments, to gather
a comprehensive three-generation family history, and to educate the patient on genetic
testing and medical management (Uhlmann et al., 2011). Our study suggests that genetic
counselors could be appropriate medical professionals to share some of the medical
management responsibilities for these patients, as typically performed in sessions with
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patients who have been found to have a genetic colon cancer diagnosis, where
management guidelines are published by several professional organizations (NCCN,
2016; Daly et al., 2016). If exercise guidelines are given to the patient from a doctor,
genetic counselors can spend more time educating the patient about these guidelines and
addressing the patient’s psychosocial needs over the course of the counseling session.
Regardless of who begins to take on a deeper role in educating these patients on
their medical management, the medial field must become aware of the needs of this
group of non-competitive athletes who are at an increased risk for SCD. Improvements
have been made on exercise guidelines, and now is the time that critical improvements be
made on the forms of communications in the office to ensure the best medical care for
our patients when they make decisions about exercise outside of the physician’s office. A
satisfying sense of understanding their new recommendations for exercise could help to
alleviate some of the psychosocial impact that comes with a life-threatening diagnosis, as
patients will better understand how to live a safe and active life when they leave the
doctor’s office.
This study targeted participants who are active members in various support
groups. The source of these participants may have created a bias in the results, as patients
may have access to more resources and support from these organizations than others who
did not respond because they are not connected with any of these support groups. This
access to support group information may influence or even bias participants’
understanding of exercise recommendations and their decisions to continue or
discontinue an exercise practice. The final population demographics were also not
representative of the general population. The majority of participants were Caucasians
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who had at least some college, obviously a highly educated population who are proactive
in seeking out additional resources for themselves. Based on the demographics results,
this study did not capture other socioeconomic populations who may be less educated,
have poor access to resources, and may be generally less knowledgeable about their
medical management recommendations.
Future research should explore various medical professionals’ perspectives on
communication of exercise guidelines to this class of patients. By interviewing physicians
or genetic counselors, the medical community could get a more accurate and
comprehensive view of what these professionals are already discussing in their practice,
how confident they are in providing patients with exercise recommendations, and how
they think this area can be improved. Another area of future research may be
understanding the role of an ICD on psychosocial impact and exercise practices after a
SADS diagnosis. Our study suggested results trending towards statistical significance
based on the impact of an ICD on exercise intensity after a diagnosis, but the number of
respondents with an ICD was small, making this is an area to be studied further.
Section 2.6 Conclusions
Our study supports a primary conclusion that individuals with a SADS diagnosis
at risk for SCD generally do not feel confident with their exercise recommendations. A
lack of patient understanding about exercise recommendations, patient education level,
and poor communication of guidelines by medical professionals can affect the duration
and intensity at which individuals exercise after a diagnosis. This may impact the safety
of the patient when the responsibility is left up to that individual. Since exercise is a key
component to quality of life in active adults, exercise recommendations cause
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psychosocial burdens on patients after a diagnosis. No clear personalized guidelines exist
that specify which medical professionals communicate these guidelines and to what detail
they are described. Genetic counselors are medical professionals with a strong medical
genetics background and have the psychosocial skills to manage a longer informational
session with patients to address this medical management discussion. Improvements need
to be made regarding how exercise guidelines are communicated to all individuals at risk
for SADS to ensure sufficient patient understanding, as this is an area in which patients
feel that they lack information and direction for their post-diagnostic exercise program.
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Chapter 3: Conclusions
Our study supports a primary conclusion that individuals with a SADS diagnosis at risk
for SCD generally do not feel confident with their exercise recommendations. A lack of
patient understanding about exercise recommendations, patient education level, and poor
communication of guidelines by medical professionals can affect the duration and
intensity at which individuals exercise after a diagnosis. This may impact the safety of
the patient when the responsibility is left up to that individual. Since exercise is a key
component to quality of life in active adults, exercise recommendations cause
psychosocial burdens on patients after a diagnosis. No clear personalized guidelines exist
that specify which medical professionals communicate these guidelines and to what detail
they are described. Genetic counselors are medical professionals with a strong medical
genetics background and have the psychosocial skills to manage a longer informational
session with patients to address this medical management discussion. Improvements need
to be made regarding how exercise guidelines are communicated to all individuals at risk
for SADS to ensure sufficient patient understanding, as this is an area in which patients
feel that they lack information and direction for their post-diagnostic exercise program.
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Appendix A: Invitation Letter to Participate in Survey
This study is being conducted as part of the requirements for a Master’s of Science
degree in Genetic Counseling at the University of South Carolina. We are interested in
better understanding your information, thoughts, and opinions about exercising before
and after your diagnosis of a heart condition.
You are being asked to participate in this study because you have been previously
diagnosed with a cardiac disease that puts you at risk for sudden cardiac death (SCD).
The purpose of this study is to explore the communication and understanding of exercise
recommendations, and the motivations for either continuing or discontinuing an exercise
practice after your diagnosis.
Your participation in this study will increase our understanding on how effectively
medical professionals communicate exercise recommendations to their patients at risk for
SCD. The results from this study will give insight on how well patients understand their
exercise recommendations, while also help us to determine the effectiveness and
usefulness of existing exercise guidelines. We believe that the results of this study can –
help us better understand patient motivations about why people with your diagnosis
choose to continue or to discontinue exercising after their diagnosis so that doctors and
other medical professionals can better address the individuals needs of their patients.
Your participation in the study is voluntary. You can skip a question or withdraw from
the study at any time. Participating in the study involves completing a short online survey
about your experiences before and after your diagnosis. The survey is anonymous,
meaning that we will not collect any personal information that could identify you or
connect you to your responses. The survey should take about 10 to 15 minutes to
complete. Questions in the survey will ask you about your medical and exercise history,
how well you understand specific topics. There are also some questions that are open for
you to answer with your opinions or in any way that you think is appropriate about your
personal experiences and opinions during your diagnosis.
The study is being conducted by Kacie Baker, a genetic counseling student at the
University of South Carolina School of Medicine for a Master’s thesis project. Peggy
Walker, a genetic counselor at the University of South Carolina, is the faculty thesis
advisor for this study. If you have any questions about this study, you may contact us:
Kacie Baker, BS
Phone: (908) 278-1203
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Email: Kacie.Baker@uscmed.sc.edu
Peggy Walker, MS, CGC
Phone: 803-549-6259
Email: mpwalker11@earthlink.net
For questions about your rights as a participant, you may contact the Office of Research
Compliance at the University of South Carolina at (803)-777-7095.
You can access the online survey by clicking the “Next” button below, indicating your
consent to participate in this study.
Thank you for sharing your information and insights.
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Appendix B: Online Survey
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Appendix C: Full ANOVA Table

Full ANOVA Table
Comparison

df

F

n

p

Communication*Minutes
Communication*Activity
Understanding*Minutes
Understanding*Activity
Education*Minutes
Education*Activity
ICD*Minutes
ICD*Activity
**=Statistically significant

1
1
1
1
1
1
1
1

1.642
4.327
2.024
4.541
4.434
.086
3.256
.069

66
66
65
65
65
65
66
67

.205
.042**
.16
.037**
.039**
.770
.076
.793
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Appendix D: 2015 Sport Classification Chart

Appendix D: 2015 Sport Classification Chart
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Appendix E: Prevalence and Information on Genetic Diseases
Disease Name
Hypertrophic
Cardiomyopathy (HCM)
Arrhythmogenic Right
Ventricular
Cardiomyopathy (ARVC)
Long QT Syndrome

Prevalence

Inheritance
Autosomal
Dominant

1 in 500
1 in 1,0001, 250

Autosomal
Dominant
Autosomal
Dominant
Autosomal
Dominant
Autosomal
Dominant
Autosomal
Recessive

1 in 2,000
Brugada Syndrome
1 in 2,000
Catecholaminergic
Polymorphic Ventricular
Tachycardia (CPVT)

1 in 10,000
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Most Common Genes
MYH7, MYBPC3,
TTNT2, TTNI3
PKP2
KCNE1, KCNE2, SCN5A
SCN5A
RYR2, CALM1
CASQ2, TRDN

